FREDUN

HealthcareDrug Manufacturers - Specialty & Generic0
Fredun Pharmaceuticals Ltd
₹1,434.6
Previous trading day close · Data updates nightly
62/100
AverageResearch Score
Market Cap
N/A
P/E Ratio
62.48
Premium
P/B Ratio
5.13
Premium
ROE
15.6%
Decent
ROCE
24.5%
Excellent
Debt / Equity
0.87
Moderate
Div. Yield
0.1%
EV/EBITDA
24.07
Fair
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
60/100
Growth
Revenue, EPS, profit growth
100/100
Valuation
PE, PB, EV/EBITDA vs sector
30/100
Risk
Debt levels, volatility, coverage
56/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
62.48(Premium)
Forward P/E
N/A
P/B Ratio
5.13(Premium)
P/S Ratio
2.23(Good)
EV/EBITDA
24.07(Expensive)
Dividend Yield
0.1%
5Y CAGR
44.4%(High growth)
Revenue Growth
90.7%(High)
Profitability
ROE
15.6%(Good)
ROCE
24.5%(Excellent)
ROA
5.8%(Average)
Net Margin
5.2%(Low)
EBITDA Margin
14.6%
Financial Health
Debt to Equity
0.87(Moderate)
Current Ratio
1.68(Healthy)
Quick Ratio
0.77(Tight)
Interest Coverage
2.25x(Low)
Technical Indicators
Based on previous trading day close
Volume
10.3K
Shareholding Pattern
Promoter
44.2%
Moderate
FII
1.1%
DII / MF
2.8%
Share FREDUN
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
FREDUN Share Price - ₹1434.60 | Research Score & Analysis | StockSage Pro